Domini Joins The Access to Medicine Foundation Investor Statement

Domini believes that access to healthcare is a critical issue for investors, one that potentially impacts the lives of billions of people in the world. The pharmaceutical industry’s ability to develop critically-needed drugs as well as their power to determine drug price give the industry significant effect over health care systems on a global scale. As a part of our long-standing commitment to healthcare issues, we have become a signatory to The Access to Medicine Foundation Investor Statement encouraging pharmaceutical companies to adopt practices that can help bridge the gaps in accessible medicine for lower-middle-income countries (LMIC).

The Access to Medicine Foundation is a Netherlands based independent non-profit organization. They promote change by analyzing data from the world’s largest pharmaceutical companies and consulting industry experts to determine the best course of action. From this data and dialogue, the foundation established three performance benchmarks to rate Pharma companies: 

  1. Access to Medicine Index
  2. Access to Vaccine Index
  3. Antimicrobial Resistance (AMR) Benchmark

These three standards highlight the best practices, risk factors, and opportunities for Pharmaceutical companies to improve in critical areas.

For over twenty years, Domini has continually engaged with pharma companies to promote positive change based on our organizational principles. Domini evaluates pharmaceutical companies against numerous data sources including the Access Index and the foundation of our investment philosophy, our Impact Investment Standards.

In a global economy, international attention to healthcare access is key to raising norms of conduct and promoting the provision of public goods. Companies that invest in their compliance with such norms help create a world of improved health, stronger communities, more satisfying workplaces, and increased public and private goods. As explicitly defined as a goal 3 of the United Nations Sustainable Development Goals or SDGs, health is a critical factor. We believe these efforts aid the long-term benefit of all, including corporations and investors. 

Past performance is no guarantee of future results. An investment in any of the Domini Funds is not a bank deposit and is not insured. The Domini Funds are not insured and are subject to market, market segment, style and foreign investing risks. Investing internationally involves special risks, such as currency fluctuations, social and economic instability, differing security regulations and accounting standards, limited public information, possible changes in taxation, and periods of illiquidity. You may lose money.

This information is provided for educational purposes only and should not be considered investment advice.

Carefully consider the Funds' investment objectives, risk factors and charges and expenses before investing. This and other information can be found in the Fund’s prospectus, which may also be obtained by calling 1-800-762-6814 (for individual investors) or 1-800-498-1351 (for financial advisors and institutional investors).

Check the background of DSIL Investment Services LLC and its investment professionals on FINRA's BrokerCheck. Before investing, consider the Domini Funds’ investment objectives, risks, charges, and expenses. View or order a prospectus. Read it carefully.

DSIL Investment Services LLC (DSILD) distributor, Member FINRA.

Domini Impact Investments LLC (Domini) is the Funds’ investment manager. The Funds are subadvised by unaffiliated entities.

Eye iconEye slash icon